Prostate cancer, NSCLC, hepatocellular carcinoma, breast cancer, pancreatic cancer, and CRC have been shown in studies to be inhibited by HO-1 expression [45,68,69,70,71,72,73,74,75]. This evidence concerns the gene HMOX1 and familial pancreatic carcinoma.